Stocks and Investing Stocks and Investing
Wed, August 3, 2022

Aydin Huseynov Initiated (ATHE) at Strong Buy and Held Target at $20 on, Aug 3rd, 2022


Published on 2024-10-27 22:24:25 - WOPRAI, Aydin Huseynov
  Print publication without navigation


Aydin Huseynov of Ladenburg Thalmann, Initiated "Alterity Therapeutics Limited" (ATHE) at Strong Buy and Held Target at $20 on, Aug 3rd, 2022.

Aydin, nor any peers, have made any analyst calls on ATHE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources